Síndrome cerebeloso secundario a metronidazol

Celia Roig-Martí; Ignacio Pérez-Catalán; Daniela Palomo-De la Sota; María José Esteve-Gimeno; Nuria ornador-Gaya; Jorge Usó-Blasco

doi:10.7399/fh.11354

Síndrome cerebeloso secundario a metronidazol

Celia Roig-Martí, Ignacio Pérez-Catalán, Daniela Palomo-De la Sota, María José Esteve-Gimeno, Nuria ornador-Gaya, Jorge Usó-Blasco

Resumen

Palabras clave

Texto completo:

PDF (English) PDF

Referencias

Grill MF, Maganti RK. Neurotoxic effects associated with antibiotic use: management considerations. Br J Clin Pharmacol. 2011;72:381-93.

Mattappalil A, Mergenhagen KA. Neurotoxicity with antimicrobials in the elderly: a review. Clin Ther. 2014;36:1489-511.

Laisa S, Briongos A, Bachiller P, Pastor L, Carreres A, Mena F. Síndrome cerebeloso inducido por metronidazol: un efecto adverso infrecuente. Rev Neurol. 2016;62(7):333-4.

Sorensesn CG, Karlsson WK, Amin FM, Lindelof M. Metronidazol induced encephalopathy: a systematic review. J Neurol. 2020;267(1):1- 13.

Ward F, Crowley P, Cotter PE. Acute cerebellar syndrome associated with metronidazole. Pract Neurol. 2015;15:298-9.

Bendesky A, Menéndez D. Metronidazol: una visión integral. Rev Fac Med UNAM. 2001;44(6):255-9.

Kim E, Na DG, Kim EY, Kim JH, Son KR, Chang KH. MR imaging of metronidazoleinduced encephalopathy: lesion distribution and diffusion- weighted imaging findings. AJNR Am J Neuroradiol. 2007;28:1652-8.

López I, Carvalho G, Povedano B. Enfermedades cerebelosas. Medicine.

;12(77):4527-36.

Zaki SA. Adverse drug reaction and causality assessment scales. Lung India. 2011;28(2):152-3.

Hobbs K, Stern-Nezer S, Buckwalter MS, Fischbein N, Finley A. Metronidazoleinduced encephalopathy: not always a reversible situation. Neurocrit Care. 2015;22(3):429-36.

DOI: http://dx.doi.org/10.7399%2Ffh.11354